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Abstract 12	
Liver sinusoidal endothelial cells (LSECs) line the low shear, sinusoidal capillary 13	
channels of the liver and are the most abundant non-parenchymal hepatic cell 14	
population. LSECs do not simply form a barrier within the hepatic sinusoids but have 15	
vital physiological and immunological functions, including filtration, endocytosis, 16	
antigen presentation and leukocyte recruitment. Reflecting these multifunctional 17	
properties, LSECs display unique structural and phenotypic features that differentiate 18	
them from capillary endothelium present within other organs. It is now clear that LSECs 19	
play a critical role in maintaining immune homeostasis within the liver and in mediating 20	
the immune response during acute and chronic liver injury. In this Review, we outline 21	
how LSECs influence the immune microenvironment within the liver and discuss their 22	
contribution to immune-mediated liver diseases and the complications of fibrosis and 23	
carcinogenesis.  24	25	
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 5	
1. Liver sinusoidal endothelial cells (LSECs) that line the hepatic sinusoids play 6	
important physiological roles and mediate the filtration and scavenger 7	
functions of the liver. 8	
2. LSECs also have innate and adaptive immunological functions including 9	
antigen presentation and maintaining the balance between tolerance and 10	
effector immune responses. 11	
3. In inflammatory liver diseases they influence the composition of hepatic 12	
immune populations by mediating diapedesis of leukocyte subsets via distinct 13	
combinations of adhesion molecules and chemokines.  14	
4. LSECs play a crucial role in the cellular cross talk which regulates 15	
progressive chronic liver disease leading to fibrosis and carcinogenesis. 16	
5. The role of LSECs in initiating immune responses and contributing to 17	
progressive liver disease make them a potential therapeutic target for treating  18	
inflammatory liver diseases. 19	
[H1]Introduction	20	
Sinusoidal endothelial cells line what constitutes a unique vascular bed in the liver, 
21	
which receives blood from both the hepatic artery and portal veins into the hepatic 
22	
parenchyma (Fig 1). Studies of these cells isolated from animals usually refer to them 
23	
as liver sinusoidal endothelial cells (LSECs), whereas isolated human cells have also 
24	
been referred to as human hepatic sinusoidal endothelial cells (HSECs). For the 
25	
purpose of this Review we use the term LSEC. The exposure of these sinusoidal 
26	
endothelial cells to blood originating from both the gut and systemic circulation means 
27	
they are ideally situated to remove and recycle blood-borne proteins and lipids. In 
28	
combination with Kupffer cells (liver-resident macrophages), LSECs constitute the 
29	
most powerful scavenger system in the body1. This activity is facilitated by the 
30	
presence of fenestrae in LSECs, their lack of a classical basement membrane and 
31	
their expression of promiscuous scavenger receptors combined with the most potent 
32	
endocytic capacity in the body2. Thus virus particles3, advanced glycation end 
33	
products4 and modified LDL5 can be cleared from the circulation within minutes by this 
34	
route.  
35	
Endothelial cells in different vascular beds are generated from common early 
36	
embryological precursors, and have broadly similar histological appearance and 
37	
functional roles throughout the body. However, extensive variations in phenotype and 
38	
function arise as a consequence of local microenvironmental signals dependent on 
39	
anatomical localisation6. The vascular architecture in the human liver is acquired by 
40	
17–25 weeks of gestation, but different vessels within the liver have distinct embryonic 
41	
3		
origins. Thus, portal vessels derive from vitelline veins, whereas sinusoids develop 
1	
from capillary vessels of the septum transversum and acquire their distinctive 
2	
fenestrated phenotype by week 20 of gestation7 under the control of GATA-48. From 
3	
this point onward, sinusoidal endothelial cells remain functionally and phenotypically 
4	
distinct from the other vascular endothelial cells in the liver microenvironment and 
5	
assume a phenotype that has many similarities with lymphatic endothelial cells9. The 
6	
unique characteristics of LSECs are presented in Box 1. Both lymphatic and sinusoidal 
7	
endothelial cells have minimal basement membranes and loosely organised cell 
8	
junctions 10 and share a complement of receptors such as LYVE-111, Prox-112, 
9	
podoplanin13 and L-SIGN14. It has been shown that the phenotype of sinusoidal 
10	
endothelial cells alters across the liver acinus; a study of human liver tissue published 
11	
in 2017 demonstrated that zone 1 LSECs are CD36hi and Lyve-1lo whereas zone 2 and 
12	
zone 3 LSECs are CD36lo, LYVE-1hi AND CD32hi 15. The presence of fenestrations or 
13	
membranous pores organised into sieve plates is a feature that also distinguishes 
14	
LSEC from the other hepatic endothelial populations.2  
15	
Fenestrations are not unique to hepatic endothelial cells and are also found in 16	
endothelium in endocrine glands such as the pancreas16, the kidney17, spleen18 and 17	
bone marrow19 and are sometimes observed in tumour vasculature20. However, unlike 18	
other fenestrated endothelial populations such as those in the kidney, hepatic 19	
fenestrations lack a diaphragm or basal lamina and are grouped into organised sieve 20	
plates, rendering LSEC highly permeable. Many studies have implicated VEGF as an 21	
essential factor for regulation of fenestrations21, but dynamic changes in hepatic 22	
fenestration number and size can occur rapidly in response to agents such as 23	
alcohol22, dietary constituents23 and fasting24 or calorie restriction25.The fenestrations 24	
act as a ‘dynamic filter’ 26to permit the access of macromolecules to parenchymal cells 25	
and in addition these pores might allow circulating viruses to gain access to 26	
hepatocytes27. Evidence from animal studies suggests that fenestrations can 27	
constitute up to 40% of the cell and that the size, distribution and clustering of the pores 28	
in sieve plates varies with the zonal distribution of the endothelium28 and across the 29	
endothelial surface. Up to a third of these pores are organised into complex labyrinths 30	
and many are associated with components of microtubules29, caveoli and coated pits 31	
to form a transport network that could impose additional regulation on the traffic of 32	
material into the cells30, enabling them to govern the movement of materials to and 33	
from the liver parenchyma.  34	
 35	
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 1	
[H1]Balancing	tolerance	and	immune	response	2	
The permissive nature of sinusoidal endothelium probably evolved to handle the 3	
constant exposure of the liver to microbial and food antigens derived from the 4	
gastrointestinal tract via the portal vein. The liver needs to ensure that damaging 5	
immune responses are not precipitated against harmless antigens, whilst at the same 6	
time being able to eliminate invading pathogens. The first site of exposure to these 7	
antigens occurs within the hepatic sinusoids and both Kupffer cells (KCs) and LSECs 8	
are important players in taking up and eliminating soluble antigens entering via the 9	
portal vein and in determining the nature of any immune response such antigens 10	
trigger.  11	
The initial critical step in an immune response is the innate pathway of antigen uptake 12	
by pattern recognition receptors31. Pattern recognition receptors are highly 13	
evolutionarily conserved and include the Toll-like Receptor (TLR) family and the 14	
scavenger receptors31. An example of how the liver regulates inflammatory and 15	
immune responses is seen in the recognition of the TLR-4 ligand lipopolysaccharide 16	
(LPS) by KCs and LSEC. Chronic exposure of both KCs and LSEC to LPS leads to an 17	
LPS-refractory state, and in LSECs specifically LPS exposure is associated with 18	
reduced nuclear translocation of nuclear-factor-kappa-light-chain enhancer of 19	
activated B cells (NF-κB) and subsequent reduced leukocyte adhesion32. This 20	
mechanism prevents the liver being in a constantly activated inflamed state in 21	
response to the constant exposure to bacterial products from the gut. Studies of other 22	
TLRs demonstrate that LSEC can respond to signals mediated via TLR1-4, 6, 8 and 23	
9, but their activation has cell-specific responses that are restricted compared with 24	
classical antigen presenting cells, thereby contributing to an organ-specific response 25	
to antigens and the tolerogenic environment of the liver33.  26	
A unique characteristic of LSEC is their expression of high levels of several scavenger 27	
receptors compared with conventional endothelium. Scavenger receptors are a 28	
diverse family of pattern recognition receptors that, like TLRs, are highly evolutionarily 29	
conserved34. In contrast to TLRs, they were believed to be functionally redundant and 30	
to perform silent uptake of ligands. However, gathering evidence suggests that this is 31	
not the case and that scavenger receptors have an important cell-specific role in 32	
immune responses34. They have been shown to promote potent pro-inflammatory and 33	
anti-inflammatory signalling as well as directly interacting with TLRs. Membrane bound 34	
scavenger receptors recognise their extracellular ligands which leads to internalisation 35	
5		
of the ligand, termed endocytosis, trafficking from the cell membrane to intracellular 1	
compartments such as the endosomes.  The high levels of scavenger receptors on 2	
LSEC give them a high endocytic capacity. One of the most extensively studied 3	
scavenger receptors on LSECs is the mannose receptor (MR)1,35,36. Others include the 4	
homologous scavenger receptors stabilin-1 and stabilin-237 and related molecules 5	
such as C-type lectins, including the type-2 receptor subclass dendritic cell-specific 6	
intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) and liver/lymph 7	
node-specific intercellular adhesion molecule 3- grabbing non-integrin (L-SIGN)38,39. 8	
The members of the C-type lectin group are involved in varied functions, from cell–cell 9	
interaction to uptake of serum glycoproteins. A third lectin with a similar structure to 10	
DC-SIGN and L-SIGN has been identified and designated the liver and lymph node 11	
sinusoidal endothelial cell C-type lectin (LSECtin)40. This lectin has been shown to be 12	
co-expressed with L-SIGN and is encoded in the same cluster of lectin encoding genes 13	
as DC-SIGN and L-SIGN. 14	
[H3]	Innate	immunity	15	
Several of the C-type lectin receptor family members have been directly implicated in 16	
viral uptake. Both DC-SIGN and L-SIGN have been shown to interact with the Ebola 17	
virus and HIV, as well as the coronavirus41,42. Both these receptors have also been 18	
shown to be expressed on LSECs and bind the E2 glycoprotein of the hepatitis C virus 19	
(HCV) and facilitate hepatocyte infection39. LSECtin has also been implicated in the 20	
uptake of SARS coronavirus and HCV43,44. The ability of LSEC to bind multiple viruses 21	
through their diverse endocytic receptors gives them a crucial role in the response to 22	
viral infections and a specific role in mediating rapid clearance of blood-borne 23	
viruses45. In a mouse model of adenovirus infection, 90% of virus is found in LSECs 24	
and 10% in KCs within a minute of intravenous viral infusion45. A study published in 25	
2017 reported that HIV-like particles are taken up by mouse LSECs at a rate of 100 26	
million particles per min.3 The transit of viruses internalised by LSECs is less well 27	
understood whereas after receptor mediated endocytosis of circulating matrix 28	
breakdown products the subsequent transit from early endosomes to late endosomes 29	
takes several hours46. LSECs enable direct entry of certain viruses such as Ebola, 30	
whereas with other viruses, such as HCV and HBV, LSECs promote hepatotropism by 31	
facilitating parenchymal cell infection47. Rapid uptake of virus can also lead to 32	
redistribution to other cells, for instance in animal models of HBV viral particles are 33	
preferentially taken up by LSECs and subsequently passed on to infect underlying 34	
hepatocytes48. In the case of HCV, innate sensing of viral infection by LSEC leads to 35	
downstream signalling and release of paracrine signals such as the pro-viral molecule 36	
6		
bone morphogenetic protein 4, which enhances viral infection of hepatocytes49. On the 1	
other hand, direct sensing of HCV RNA in LSECs also leads to the release of IFN I/III 2	
rich exosomes that inhibit HCV replication50. The balance of such responses will 3	
determine whether virus infection is established or prevented, thereby emphasising 4	
the critical role that LSEC play in hepatotropic viral infections.  5	
[H3]Adaptive	immunity	6	
LSEC not only regulate innate immune responses but also directly regulate adaptive 7	
immune responses through antigen presentation to T cells (FIG. 2). Knolle’s group 8	
demonstrated that LSECs can cross-present antigen to CD8+ T cells51 by using 9	
scavenger receptors, notably the mannose receptor, to take up, process and transfer 10	
antigen to MHC class I52. The presentation of antigen, including oral antigens, by 11	
LSECs drives a tolerogenic response in naïve CD8+ T cells mediated by upregulation 12	
on LSECs of the co-inhibitory molecule programmed death-ligand 1 (PD-L1), also 13	
known as CD274 or B7 homolog 1, which can activate its receptor PD-1 of naïve T 14	
cells 51,53,54. Endocytosis of antigens by the mannose receptor on LSECs has been 15	
shown to promote CD8+ T cell tolerance55, including tolerance to tumour antigens56. 16	
However, it is crucial that rapid effector responses can be generated locally to harmful 17	
pathogens; consistently, LSEC-driven T cell activation changes in response to antigen 18	
load and local inflammatory factors. For example, in a culture model with mouse 19	
LSECs in which antigens at varying concentrations were delivered to LSECs for cross 20	
presentation to CD8+ T cells, high antigen concentrations led to a shift from tolerogenic 21	
to effector T cell differentiation57 as a consequence of enhanced TCR signalling that 22	
overcame PD-1 mediated tolerogenic responses. This response is also affected by 23	
local levels of IL-2. Furthermore, rapid activation of CD8+ T cells by LSECs occurs in 24	
the presence of IL-6 trans-signalling and this activation not only drives rapid effector T 25	
cell differentiation but also primes T cells to respond to other inflammatory signals and 26	
leads to sustained effector responses58.  27	
 28	
LSEC also express MHC class II molecules that enable them to present antigens to 29	
CD4+ T cells59. However, the low levels of co-stimulatory molecules on LSECs means 30	
that rather than driving naïve CD4+ T cell differentiation to T helper cells60 they promote 31	
the development of regulatory T cells61. In vivo studies have shown that these 32	
tolerogenic properties of LSEC can control autoimmunity. Circulating inflammatory 33	
CD4+ T cells (Th1 and Th17 cells) were shown to interact repeatedly with liver 34	
sinusoidal endothelium and this interaction successfully suppressed inflammatory 35	
cytokine release in mice62. The induction of autoantigen-specific T regulatory cells by 36	
7		
LSECs was also shown to have important systemic effects by ameliorating damage in 1	
mouse models of autoimmune CNS disease63,64. This finding has therapeutic 2	
implications for systemic as well as local immunity and has led to development of 3	
nanotechnology-based strategies to deliver autoantigen to LSECs as part of tolerance 4	
induction protocols64 C-type lectins also contribute to the unique ability of LSECs to 5	
control T cell differentiation. Thus, LSECtin on LSECs inhibits T cell activation and 6	
effector functions through its interaction with CD44 on activated T cells 65.  7	
[H1]	LSECs	in	inflammatory	liver	disease	8	
In addition to their roles as pathogen recognition and antigen presenting cells, LSECs 9	
also have a critical role in regulating the recruitment of leukocytes into liver tissue (Box 10	
2). A key step in the progression of liver injury or infection, regardless of aetiology, is 11	
the development of hepatitis as a consequence of the recruitment of leukocytes from 12	
the circulation. The balance and retention of immune subsets within the liver 13	
determines whether injury resolves, persists or progresses to either liver failure or 14	
chronic hepatitis and cirrhosis66. Leukocyte recruitment from the blood occurs as a 15	
consequence of a multistep adhesion cascade that enables leukocytes flowing in the 16	
circulation to be captured by activated endothelial cells and then to migrate through 17	
the endothelium towards sites of infection or injury67. The cascade consists of 18	
sequential steps mediated by interactions between receptors on the surface of 19	
leukocytes and endothelial cells. The general paradigm applies to all vascular beds, 20	
but tissue and inflammation specific interactions provide powerful local regulation of 21	
where, when and which leukocytes are recruited. The steps in the cascade are broadly 22	
described as rolling or tethering, in which the leukocyte is captured from the circulation 23	
and induced to roll on the endothelial surface. In most vascular beds this step is 24	
mediated by a family of receptors termed selectins but other receptors are involved 25	
under specific circumstances, such as in the hepatic sinusoids68. Leukocyte rolling is 26	
followed by activation of leukocyte integrins in response to tissue-derived 27	
chemoattractant cytokines (chemokines) sequestered in the endothelial 28	
glycocalyx69,70, which leads to firm adhesion mediated by integrins binding to 29	
immunoglobulin superfamily members on the endothelial surface. This adhesion is 30	
followed by intravascular crawling of the adherent leukocyte on the endothelium, 31	
before the final step of transmigration in which the leukocyte migrates across the 32	
endothelium, through the post-endothelial tissue and into the liver parenchyma. The 33	
transmigration step is mediated by a complex series of receptor–ligand interactions 34	
8		
with cytoskeletal changes in both the endothelial cells and the leukocytes and which 1	
enable the cell to cross the endothelium without disrupting the vascular barrier71.  2	
Cell recruitment to the liver has several features that are distinct from the general 3	
adhesion cascade (Figure 3). Recruitment of the majority of leukocytes occurs within 4	
the sinusoidal channels of the liver, in contrast to most other organs in which 5	
recruitment occurs within the post capillary venules72. Furthermore, the recruitment of 6	
leukocytes subsets to the liver is regulated by specific combinations of typical and 7	
atypical adhesion molecules reflecting the unique phenotype and structure of LSECs, 8	
and the anatomy and rheology of the sinusoids (Box 1). The sinusoids are narrow, in 9	
places no wider than a flowing leukocyte, and characterised by low shear stress. These 10	
properties mean that the initial recruitment step does not require rolling and in most 11	
circumstances is selectin-independent. As a consequence, sinusoidal endothelium 12	
expresses minimal levels of selectins in vivo72,73. A summary of the key adhesion 13	
factors is outlined in Table 1.  14	
[H3]Immunoglobulin	superfamily	15	
The conventional endothelial adhesion molecules that mediate firm adhesion of 16	
leukocytes, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion 17	
molecule-1 (VCAM-1)70,74, are expressed at high levels on inflamed LSECs75. Their 18	
role in lymphocyte recruitment to the liver has been confirmed in both in vitro and in 19	
vivo assays. VCAM-1, which binds the integrin α4β1 expressed on lymphocytes, has 20	
an important role in capturing lymphocytes from blood flow and mediating 21	
stabilisation66,76. ICAM-1 binds to αLβ2 integrin to support firm adhesion within the 22	
hepatic sinusoids72. Another family member is the mucosal vascular addressin cell 23	
adhesion molecule-1 (MAdCAM-1), which binds to the integrin α4β7 and plays a major 24	
part in lymphocyte homing to the gut via mucosal vessels77. Our group demonstrated 25	
that this receptor was also upregulated in the liver in some chronic liver diseases, in 26	
which it promotes the recruitment of T cells activated in the gut that express high levels 27	
of α4β7, thereby contributing to the link between IBD and inflammatory liver disease78,79. 28	
Although many of these immunoglobulin superfamily members are regulated by pro-29	
inflammatory cytokines, their adhesive function is also dependent on the formation of 30	
cell-surface platforms regulated by the tetraspanin family of receptors, which form 31	
microdomains and associate laterally with ICAM-1 and VCAM-180,81. For example, our 32	
group confirmed that the tetraspanin CD151 associates with VCAM-1 in LSECs and 33	
regulates lymphocyte adhesion under shear stress82.  34	
9		
[H3]Atypical	adhesive	and	migratory	routes	1	
In addition to conventional adhesion molecules, our group and others have 2	
demonstrated that LSECs use atypical adhesion molecules to regulate leukocyte 3	
recruitment. Vascular adhesion protein-1 (VAP-1) is a membrane bound amine 4	
oxidase that was originally shown to mediate lymphocyte binding to high endothelial 5	
venules, the specialised post-capillary venules found in lymph nodes83. Further studies 6	
confirmed that VAP-1 was expressed at high levels in chronic liver disease and 7	
mediated adhesion and transmigration across LSEC84. Models of in vitro and in vivo 8	
inflammatory liver injury corroborated its role in mediating recruitment during liver 9	
inflammation. VAP-1 has unique properties generated by its enzyme activity that can 10	
upregulate expression of adhesion molecules and chemokines in LSECs, thereby 11	
amplifying leukocyte recruitment85-88. The scavenger receptor family of endothelial 12	
receptors also contribute to leukocyte recruitment to the liver. Stabilin-2 was shown to 13	
regulate lymphocyte adhesion to LSECs via the integrin αMβ289 and its homologue, 14	
stabilin-1, also known as common lymphatic endothelial and vascular endothelial cell 15	
receptor (CLEVER-1), was originally shown to mediate recruitment across lymphatic 16	
endothelium90. Similarly expression of stabilin-1 is upregulated in chronic liver disease 17	
and hepatocellular carcinoma, in which it mediates transmigration of lymphocytes 18	
across LSECs under shear stress91. 19	
Following adherence, leukocytes crawl across the endothelial surface before 20	
undergoing transmigration usually via endothelial junctions, termed the ‘paracellular’ 21	
route92,93. Several studies have demonstrated that lymphocyte interactions with LSECs 22	
within the sinusoids trigger important immune effector mechanisms94,95, which might 23	
influence the infiltration and positioning of cells within the liver in inflammatory liver 24	
diseaes75. Thus, it is important to understand how the process of transendothelial 25	
migration through LSECs is regulated. Visualization of this process using confocal 26	
imaging of lymphocytes migrating across LSECs under shear stress demonstrated that   27	
approximately 50% of cells took a ‘transcellular’ route of migration, and migrated 28	
directly through the endothelial body91, as opposed to the conventional paracellular 29	
route. This transcellular migration route involved the formation of ICAM-1 rich channels 30	
to facilitate lymphocyte migration. Although transcellular migration has been noted in 31	
some other specialized endothelial beds, its function and molecular basis remain 32	
poorly understood96. Transendothelial migration is a multi-step process involving 33	
different combinations of receptors that enables preferential recruitment of particular 34	
leucocyte subsets, as described in the following sections. An additional step in 35	
migration was described in 2016, in which lymphocytes migrate into LSECs and then 36	
10		
crawl within the endothelial cell to the cell junction, through which they enter the 1	
adjacent endothelial cell97.  This process, which we term ‘intracellular crawling’, is 2	
dependent on IFNγ and could not be detected when LSEC were stimulated by other 3	
interferon family cytokines.  We found that IFNγ treatment did alter the cytoskeleton of 4	
LSECs which might promote ‘intracellular crawling’. This process was also facilitated 5	
by the unique junctional complexes between LSECs. The functional consequences of 6	
intracellular crawling are yet to be elucidated but could have an important role in 7	
lymphocyte positioning in liver tissue. 8	
[H3]Chemokines		9	
Chemokines are a family of small secreted proteins ranging from 67-127 amino acids 10	
in size that bind to heparin sulphate on proteoglycans98,99. They play central  parts in 11	
leukocyte migration during homeostasis (in development and localization in 12	
secondary lymphoid organs) as well as within tissues during inflammatory responses 13	
by binding to G protein-coupled receptors on the surface of leukocytes. Upregulation 14	
of several chemokines on liver vasculature has been demonstrated in a range of 15	
chronic inflammatory liver diseases, including alcoholic liver disease, primary 16	
sclerosing cholangitis and chronic rejection100-104. In these conditions, chemokines 17	
seem to be compartmentalized to the sinusoidal vasculature and portal vessels and 18	
have a substantial influence on immune cell localization and subsequent disease 19	
progression 101,102,105. T cell migration across sinusoidal endothelium is mediated by 20	
the interferon-inducible chemokines CXCL9 and particularly CXCL10, which bind the 21	
receptor CXCR3106,107. In other diseases, including chronic HCV infection, the 22	
chemokine CXCL16, which exists in a transmembrane form, is expressed on 23	
sinusoidal endothelium, hepatocytes and bile ducts, enabling it to regulate the 24	
recruitment and retention of CXCR6+ effector T cells within the liver108,109. Subsets of 25	
Natural Killer (NK) and NK T cells express high levels of CXCR6 that enable them to 26	
interact with CXCL16 on sinusoidal endothelium; this interaction promotes active 27	
migration along the sinusoids as part of a process of ongoing immune surveillance 28	
and patrolling110. Studies in mouse liver endothelial cells have shown that a vital 29	
property of chemokine-mediated recruitment is the transcytosis of chemokines from 30	
the basolateral side to the luminal side of sinusoidal endothelial cells111. This process 31	
is clathrin-dependent and promotes the transendothelial migration of lymphocytes 32	
across LSECs, and inhibition of this pathway reduces CD4+ Tcell recruitment during 33	
liver injury112.  34	
 35	
11		
[H1]Immune	subset	recruitment	1	
The balance of immune subsets determines the progression and outcome of immune 2	
responses within the liver: persistent effector responses will drive chronic inflammatory 3	
conditions, whereas excessive immunosuppressive immune subset populations 4	
promote pathogen escape and tumour formation113-115. In addition to the key mediators 5	
of immune cell recruitment discussed earlier, there is now evidence that immune cell 6	
subsets utilise distinct combinations of these factors to migrate through the hepatic 7	
sinusoids under specific circumstances.  8	
[H3]T	cells	9	
T helper cells are divided into multiple functional subsets based on the cytokines they 10	
secrete and dependent on the microenvironment in which they are activated by 11	
antigens. In a concanavalin-A liver mouse inflammation model, Th1 recruitment 12	
through the sinusoids was mediated by α4β1 integrin interactions whereas Th2 cells 13	
used VAP-185. Both effector Th17 and regulatory T (Treg) cells found in the liver 14	
express high levels of the chemokine receptor CXCR3 and use it to migrate across 15	
LSECs116,117. Subsequent signals determine where these cells localise within the liver, 16	
with CCR6+ Th17 cells migrating towards their ligand CCL20 secreted by bile ducts 17	
whilst Tregs respond to different chemokines as a consequence of their expression of 18	
CCR5, CCR4 and in some cases CCR10118-120. Tregs were also shown to use a distinct 19	
combination of adhesion receptors, involving CLEVER-1/stabilin, ICAM-1 and VAP-1, 20	
to migrate across human LSECs under flow91, whereas recruitment of CD8+ T cells to 21	
the mouse liver is primarily dependent on ICAM-1 expression by LSECs with a lesser 22	
contribution from VCAM-1121,122. In autoimmune hepatitis and primary sclerosing 23	
cholangitis (PSC) associated with IBD, LSECs present the chemokine CCL25, which 24	
can trigger CCR9+ gut homing lymphocyte interactions with MAdCAM-1 to promote 25	
recruitment of mucosal T cells104,123.  26	
These distinct mechanisms of migration across LSECs are probably influenced by 27	
epithelial responses to tissue injury118,124, stromal signals125 and cooperative 28	
interactions between several cell types in the sinusoid. For instance, in a model of HBV 29	
infection, effector CD8+ T cells were shown to arrest in the sinusoids by interacting with 30	
platelets adherent to the sinusoidal surface via hyaluronan dependent mechanisms95. 31	
Subsequently, the CD8+ T cells crawled along the sinusoids, probing through the LSEC 32	
fenestrae for viral antigens presented by underlying hepatocytes. Antigen recognition 33	
as a consequence of this probing behaviour led to effector functions by a diapedesis-34	
independent process. A human model of cytomegalovirus (CMV) infection of LSECs 35	
led to the recruitment of effector T cells and activated Tregs in an LFA-3 dependent 36	
12		
mechanism126. In this study, CMV infected human LSEC upregulated LFA-3 at 1	
intercellular junctions and during effector T cell recruitment the interaction of LFA-3 2	
with its ligand, CD2 on T cells, contributed to Th1 activation.  3	
[H3]B	cells	4	
Although B cells are present in substantial numbers in chronically inflamed liver tissue, 5	
the molecular mechanism regulating their recruitment from blood into hepatic tissue is 6	
poorly understood. Our group demonstrated that B cell recruitment across human 7	
LSECs under flow was initially mediated by VCAM-1-dependent capture followed by 8	
limited intravascular crawling, compared with T cells127. Interestingly, the receptors 9	
involved in transmigration of B cells included ICAM-1, VAP-1 and CLEVER-1/stabilin-10	
1 all of which are also involved in Treg transmigration across LSEC.  11	
[H3]Neutrophils	12	
Neutrophils are one of the earliest immune cells to be recruited to a site of tissue injury 13	
and they are also recruited into the liver via the hepatic sinusoids128. It was originally 14	
thought that their migration was mediated by simple physical trapping within the narrow 15	
sinusoidal channels, but work from McDonald et al. implicated a complex multistep 16	
recruitment process involving interactions between sinusoidal hyaluronan and CD44 17	
on the neutrophil surface129. Whereas neutrophil interactions in post-sinusoidal 18	
venules followed a conventional rolling mediated by selectins and integrin-mediated 19	
adhesion, this was found not to be the case in the sinusoids, where the majority of 20	
neutrophil extravasation took place. They found that hyaluronan was highly expressed 21	
in liver sinusoids and mediated the recruitment of neutrophils in response to LPS 22	
challenge. This interaction was dependent on CD44 binding to hyalorunan rather than 23	
the other hyaluronan receptor, receptor for HA-mediated motility (RHAMM). A study 24	
published in 2014 also highlighted the importance of TLRs for neutrophil recruitment. 25	
TLR2/S100A9 signalling in particular promoted the production of the chemokines 26	
CXCL1 and CXCL2, which are known to mediate neutrophil migration, by liver 27	
macrophages  in acute and chronic mouse models of liver injury130. 28	
 29	
[H3]Monocytes	30	
In addition to the activation of resident Kupffer cells, monocytes and macrophages are 31	
also recruited to the liver from the circulation during inflammation or in response to 32	
injury. Kupffer cells are yolksac-derived tissue macrophages found within the hepatic 33	
sinusoids; they are immobile and probe the environment with pseudopods131. The 34	
response to liver injury also includes an influx of monocytes, which have a major role 35	
13		
in regulating inflammation, regeneration and repair and fibrosis132. Furthermore, acute 1	
liver injury is associated with an initial influx of GATA6+ peritoneal macrophages that 2	
enter directly through the mesothelium in a process dependent on CD44 and the 3	
DAMP molecule ATP131. This entry is followed by the recruitment of CCR2+ monocytes 4	
from the circulation133. The subsequent recruitment signals governing monocyte 5	
migration through the sinusoids are less well characterised but several key factors 6	
have been determined. The dominant chemokine receptor mediating migration of 7	
CD16+ monocytes across LSECs is CX(3)CR1 binding to its ligand CX(3)CL1, one of 8	
the few transmembrane chemokines, which is restricted to bile ducts in the normal liver 9	
but expressed at high levels on inflamed sinusoidal endothelium134. In this study, VAP-10	
1 also contributed to adhesion and transendothelial migration of CD16+ monocytes 11	
across LSECs. The accumulation of CD14++CD16+ monocytes has been reported in 12	
inflammatory liver disease, which is due in part to the preferential migration of this 13	
subset across LSECs compared to CD14++CD16- cells135. Monocytes are known to 14	
undergo a phenomenon of bidirectional movement across endothelium that involves a 15	
reverse migration step136,137. This migratory behaviour has been confirmed in LSECs 16	
and might have a marked effect on the fate of monocytes and the outcome of liver 17	
injury, because monocyte subsets which undergo reverse transmigration are 18	
predominantly proinflammatory CD16+ monocytes. By contrast, those remaining in the 19	
subendothelial space are anti-inflammatory monocytes that suppress T cells and 20	
promote endotoxin tolerance138.  21	
 22	
[H1]Interaction with other liver cells 23	
Although we have focused on leukocyte interactions with LSECs, the cross talk 24	
between LSECs and other liver cell populations will also influence the progression of 25	
chronic inflammatory liver diseases. Kupffer cells are found within the hepatic 26	
sinusoids in close association with LSECs and are also equipped to sense tissue injury 27	
from infection and toxins. The release of DAMPs and PAMPs triggers the 28	
inflammasome pathway in Kupffer cells 139. Inflammasome activation is a key step in 29	
the progression of parenchymal liver injury, such as alcoholic liver disease, in which 30	
the release of danger signals from damaged hepatocytes stimulates the release of pro-31	
inflammatory mediators from Kupffer cells 140. Despite poor understanding of the cross-32	
talk between LSEC and Kupffer cells, the release of these mediators probably 33	
influences LSEC phenotype and activation and leads to subsequent leukocyte 34	
recruitment141,142. Furthermore, Kupffer cells can promote LSEC capillarization, 35	
14		
whereby LSEC morphology becomes more vascular or capillary like with a loss of 1	
fenestrations and a characteristic basement membrane is formed143,144. 2	
The other cell type that populates the sinusoids is the hepatic stellate cell (HSC), 3	
positioned within the Space of Disse. The central role of HSCs in extracellular matrix 4	
production in chronic liver disease is well established145. It is now known that LSECs 5	
play an important role in maintaining the quiescence of HSCs and this ability is lost 6	
during capillarisation of LSECs, which permits HSC activation and fibrogenesis21,146. 7	
Activated liver myofibroblasts, derived predominantly from HSCs, also have a role in 8	
the subsequent migration and positioning of lymphocytes following their recruitment 9	
through LSECs. This process is mediated by distinct combinations of cytokines 10	
including IL-6, VEGF and chemokines released by myofibroblasts125.  11	
LSECs also play a key role in maintaining hepatocyte homeostasis. LSEC 12	
fenestrations enable bidirectional transport of metabolites between the circulation and 13	
the liver parenchyma1. LSECs also facilitate circulating T cells to interact with 14	
hepatocytes by allowing T cells to extend cell surface protrusions through LSEC 15	
fenestrations147. In chronic liver injury, microparticles are released from hepatocytes, 16	
leukocytes and LSEC and provide another route for cell–cell communication148. 17	
Paracrine factors released from hepatocytes influence the expression of adhesion 18	
molecules on overlying LSECs and can promote the recruitment of flowing 19	
lymphocytes from the sinusoids124. This mechanism might be particularly important in 20	
liver cancer because malignant transformation of hepatocytes enhances their ability to 21	
secrete chemokines CXCL10, CCL2 and CCL3 and to upregulate expression of ICAM-22	
1 and VAP-1 on co-cultured LSECs103,149. Work from our group has demonstrated that 23	
factors secreted by hepatoma cells upregulate the expression of the tetraspanin 24	
CD151 in LSECs, which promotes VCAM-1 mediated recruitment of lymphocytes82.  25	
[H1]Therapeutic	opportunities	26	
The evidence presented here highlights the crucial role played by LSECs in regulating 27	
the inflammatory response to liver injury. This importance makes them and the 28	
molecules they express attractive therapeutic targets in inflammatory liver 29	
disease150,151. VAP-1 is a good example152, with studies confirming that inhibition of 30	
both its enzymatic activity or antibody blockade of its adhesive function reduces 31	
hepatic inflammation and fibrosis in mouse liver injury models87, and this work has led 32	
to a clinical trial of a humanised antibody against VAP-1 that is currently underway 33	
(BUTEO, NCT02239211) in patients with PSC. Chemokines and adhesion molecules 34	
expressed by inflamed LSECs are also potential targets for anti-inflammatory therapy 35	
15		
in liver disease. For example, patients with PSC have been treated with NI-0801, a 1	
humanized monoclonal antibody against CXCL10. Interestingly, the high production 2	
rate of CXCL10 by the inflamed liver made it difficult to achieve sustained 3	
neutralization of the chemokine in vivo, despite evidence that the antibody could “strip” 4	
chemokine from the sinusoidal endothelial bed. Although the drug was well tolerated 5	
and demonstrated immunological changes, the overall results were negative.  (K de 6	
Graaf et al. submitted for publication). Thus, therapies directed at the chemokine 7	
receptors themselves might have merit, and evidence from early trials using the dual 8	
CCR2–CCR5 antagonist cenicriviroc in patients with NASH suggests that such 9	
treatment can induce a persistent blockade153. 10	
  11	
There is also a strong rationale to target gut-tropic chemokines in patients with liver 12	
diseases associated with IBD. Of particular relevance is PSC, a progressive biliary 13	
disease that is associated with IBD in 80% of cases and which affects ~8% of patients 14	
with IBD, particularly those with colitis154. Under physiological conditions expression of 15	
CCL25 and MAdCAM-1 is absent from the liver, but in PSC both proteins are 16	
detectable on hepatic endothelium and support the aberrant recruitment of α4β7+ 17	
CCR9+ effector lymphocytes from the gut. Clinical trials are currently being considered 18	
to target the α4β7-MAdCAM-1 pathways in PSC using antibodies developed for treating 19	
IBD. 20	
The tolerogenic capabilities of LSECs have also been targeted therapeutically. 21	
Nanoparticles loaded with autoantigen can be targeted to LSECs as a consequence 22	
of their potent scavenging capability; the ability of LSECs to take up molecules using 23	
their scavenger receptors is an excellent way of potentially targeting a range of 24	
therapies to the liver. Presentation of delivered autoantigens by LSECs to naive T cells 25	
results in the generation of autoantigen-specific regulatory T cells that can suppress 26	
systemic as well as local autoimmune responses. This strategy could be applied to a 27	
wide range of autoimmune and allergic conditions64. Targeting LSEC stabilin-1 and 28	
stabilin-2 with nanoparticle-based drugs155 has been suggested as a way to deliver 29	
local treatment to manage a range of conditions including ischaemia–reperfusion injury 30	
(a specific type of injury that follows liver surgery and transplantation which is a 31	
biphasic process involving hypoxia followed by restoration of blood flow and 32	
reoxygenation)  and NAFLD. Similarly, blockade of LSECtin or the related molecule 33	
DC-SIGNR has been shown to reduce the metastasis of colon cancer cells to the liver 34	
via impairment of interactions with LSEC in mouse models156,157. 35	
16		
During cirrhosis and chronic hepatitis, LSECs can undergocapillarisation158. This 1	
process is associated with loss of GATA4-dependent signals8, upregulation of CD31 2	
and VCAM-1 and loss of fenestrations158-160. The number of fenestrations per 3	
endothelial cell not only decreases with disease161-163 but also with ageing164, and this 4	
phenotypic change is governed by p19ARF and p53-dependent signalling165. These 5	
changes might impede the transfer of materials to or from the parenchyma and 6	
contribute towards regional hepatocyte hypoxia. Capillarisation is mechanistically 7	
linked to the development of chronic inflammatory disease. In rodent models, it is 8	
associated with enhanced antigen presentation and cytotoxic T cell priming during 9	
fibrosis151, and in NASH capillarisation precedes and contributes to the transition from 10	
simple steatosis to steatohepatitis159. The changes that occur in LSECs in response to 11	
chronic inflammation also affect angiogenic pathways. Neo-angiogenesis is a key 12	
feature of chronic liver disease and the majority of neo-vessels arise from portal vein 13	
branches and are closely associated with areas of fibrogenesis166,167 A key initiating 14	
step is the capillarisation of LSECs, which leads to increased hepatocyte hypoxia and 15	
subsequent release of pro-angiogenic factors168,169. The LSEC response is context 16	
specific; for example, acute injury can induce CXCR7 expression and a regenerative 17	
response, whereas chronic injury leads to CXCR4 induction, HSC proliferation and 18	
fibrogenesis170. During ischaemia-reperfusion injury LSEC develop a proinflammatory, 19	
prothrombotic phenotype associated with vasoconstriction171. These changes have 20	
been directly linked to neutrophils because IL-33 released by LSECs during 21	
ischaemia–repurfusion injury triggers the release of neutrophil extracellular traps 22	
(NETs), which exacerbate acute hepatic injury172. In chronic injury, the changes in 23	
endothelial phenotype that accompany capillarisation and precede fibrosis have been 24	
linked to alterations in signalling via the hedgehog gene family173 and lead to 25	
vasocontriction and increased intrahepatic vascular resistence due to reduced nitric 26	
oxide production by LSEC174. Tumour progression in hepatocellular carcinoma is 27	
associated with changes in the phenotype of peritumoural LSECs and increased 28	
production of angiogenic factors including IL-6175,176.  29	
These changes in LSECs therefore present opportunities for therapeutic intervention. 30	
For example, pharmacological therapy in the form of a soluble guanylate cyclase 31	
activator which restores fenestrations has been linked to fibrosis regression in rodent 32	
models21 and it might also be possible to use GATA-4 mediated cellular 33	
reprogramming to restore the differentiated phenotype of LSECs and promote fibrosis 34	
resolution8. Similarly, therapies that restore normal hedgehog signalling promote 35	
regression of capillarisation and the reappearance of fenestrations, which suggests a 36	
17		
potential pathway for reversal of fibrosis and the restoration of lipid transport173. 1	
However, studies testing cessation of VEGF-based cancer therapies also highlight 2	
how important the development of fenestrations can be in the context of metastasis, 3	
and go some way in explaining poor performance of some strategies using anti-VEGF 4	
drugs as cancer treatments. Withdrawal of anti-VEGF- antibody therapy is associated 5	
with development of hyperpolarised LSECs and promotion of hepatic metastasis177. 6	
Thus, low-dose, non-stop anti-angiogenic therapy might present a future solution to 7	
minimise these effects. 8	
[h1]Conclusions 9	
Sinusoidal endothelial cells have complex interrelated roles in the maintenance of liver 10	
homeostasis and are implicated as drivers of inflammation and fibrogenesis in liver 11	
disease. Their unique positioning, phenotype and function make them attractive 12	
candidates for organ-specific therapy and it is likely that more therapies targeting these 13	
cells will be tested in the future as new treatments to reduce liver injury and 14	
inflammation and to prevent or reverse fibrogenesis. In the absence of licenced 15	
antifibrotic therapies, strategies to maintain LSEC differentiation and to inhibit their 16	
ability to recruit harmful pro-inflammatory leukocytes through the selective 17	
orchestration of immune cell traffic might provide vital tools to halt the increase in 18	
mortality linked to chronic liver failure.  19	
  20	
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Box	1	|	Unique	characteristics	of	liver	sinusoidal	endothelium	1	 Morphological	appearance		 Fenestrated,	continuous	endothelium	with	minimal	basement	membrane	in	normal	conditions	Fenestrations	can	be	organized	into	sieve	plates	and	range	from	around	50-100nM	in	diameter	Expression	of	endothelial	markers		
CD31	present	at	low	levels	Von	Willebrand	factor	expression	is	controversial	but	can	be	detected	in	human	LSECs	in	the	context	of	liver	injury	CD34	is	absent	or	only	expressed	at	low	levels	CD105	(endoglin)	is	present	CD36	is	present	at	a	much	higher	level	than	vascular	endothelium	E-selectin	is	absent	on	unstimulated	cells	but	expression	can	be	induced,	albeit	at	lower	levels	than	vascular	endothelium	in	inflammatory	conditions	Endocytic	capabilities		 High	and	rapid	clathrin-mediated	endocytosis	of	many	substances,	ranging	from	cellular	components	such	as	collagen	and	hyaluronan	to	acetylated	LDL,	immune	complexes	and	exogenous	antigens	such	as	ovalbumin	via	key	receptors	Expression	of	scavenger	receptors		
LSEC	have	very	potent	scavenger	capabilities	by	virtue	of	expression	of	many	scavenger	receptors,	including	Mannose	receptor(CD206),	FcgRIIb,	Stabilin-1	(Clever-1),	Stabilin-2,	Scavenger	receptors	B1	and	B2,L-SIGN,	LYVE-1	and	LRP-1	Junctional	structure		 ‘Mixed’	type	of	junctions	having	some	features	of	tight	junctions	but	generally	showing	lower	or	absent	claudin-5	and	occludin	compared	to	vascular	endothelium		VE-Cadherin	can	be	present	in	a	disease	setting	Adhesion	molecules		 LSEC	constitutively	express	low	levels	of	ICAM-1,	ICAM-2and	VCAM-1	Selectin	expression	is	considered	to	be	minimal	in	most	circumstances	Also	more	unusual	‘adhesion’	and	scavenger	receptors	such	as	Clever-1,	VAP-1,	DC-SIGN,	L-SIGN,	LYVE-1	and	MAdCAM-1	can	contribute	to	recruitment	of	immune	cells	in	a	disease	specific	context	Chemokine	expression	 Minimal	chemokine	expression	is	seen	on	unstimulated	LSECs	although	they	will	express	factors	such	as	CXCL9-
31		 11,	CCL25,	CX3CL1	and	CXCL16	in	response	to	cytokine	stimulation.	They	can	also	present	chemokines	derived	from	neighbouring	or	underlying	cells	to	promote	binding	and	migration	of	immune	cell	subsets		1	 	2	 	3	 Box	2	|	The	role	of	LSECs	in	progression	of	chronic	liver	diseases	4	
Hepatitis	C	5	 	Recruitment	and	positioning	of	effector	T	cells	in	hepatitis	C	through	sinusoidal	6	 endothelial	expression	of	adhesion	molecules	ICAM-1,	VCAM-1	,	VAP-1	and	presentation	7	 of	CXCR3	ligands	associated	with	compartmentalisation	within	the	parenchyma102,109.	8	 Retention	of	CXCR6+	T	cells	through	the	expression	of	its	ligand	CXCL16	108..	9	
Primary	sclerosing	cholangitis	10	 Aberrant	homing	of	mucosal	effector	lymphocytes	through	expression	of	MAdCAM-1	11	 and	CCL25	on	hepatic	sinusoidal	endothelium78,104.	VAP-1	regulates	the	expression	of	12	 MAdCAM-1	by	deaminating	primary	amines	and	driving	a	NF-KB	dependent	pathway	13	 86,88.	14	
Autoimmune	hepatitis	15	 Initial	T	cell	mediated	damage	directed	to	sinusoidal	endothelium	as	initiating	event	in	16	 models	of	autoimmune	hepatitis141.	Upregulation	of	adhesion	molecules	such	as	17	 MAdCAM-1	promotes	lymphocyte	recruitment78.	Development	of	LSEC-reactive	18	 autoantibodies	leads	to	capillarisation	of	sinusoidal	endothelium	and	progressive	liver	19	 disease142.	20	
Alcoholic	liver	disease	and	NAFLD	21	 Defenestration	and	activation	are	early	changes	in	models	of	alcoholic	and	fatty	liver	22	 disease159,160.	The	presentation	of	chemokines	by	sinusoidal	endothelium	leads	to	23	 recruitment	of	T	cells	with	compartmentalisation	leading	to	progressive	disease101.	24	
Fibrosis	25	 LSECs	prevent	hepatic	stellate	activation21.	This	ability	to	maintain	HSC	quiescence	is	26	 lost	during	capillarisation	of	LSEC	driven	by	chronic	injury146.	Capillarisation	leads	to	27	 impaired	eNOS	activity	leading	to	low	nitric	oxide	production174	and	increased	hedgehog	28	 signalling173.		29	
Hepatocellular	cancer	30	 Endothelial	transdifferentiation	with	loss	of	several	LSEC	markers176.	Presentation	of	31	 CXC	and	CC	chemokines	and	expression	of	ICAM-1,	VAP-1	and	CD151	promotes	32	 lymphocyte	recruitment	to	HCC	103,149,82,.	Stabilin-1	expression	might	promote	Treg	33	 specific	recruitment91.		34	 	35	 	36	
32			1	
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Tables:	3	
	4	 Table	1	|	Mediators	of	immune	cell	recruitment	across	liver	sinusoidal	endothelial	cells	5	 	6	 Adhesion	factor	 Ligand	 Function	ICAM-1	 αLβ2	 Firm	adhesion	of	CD4	cells	and	CD8	cells,	transmigration	of	Tregs	and	B	cells	VCAM-1	 α4β1	 Capture	and	firm	adhesion	of	T	and	B	cells	VAP-1	 unknown	 Adhesion	and	transmigration	of	lymphocytes	and	monocytes	Stabilin-1	(CLEVER-1)	 unknown	 Transmigration	of	CD4	T	cells,	predominantly	Tregs	Stabilin-2		 αMβ2	 Adhesion	of	lymphocytes	MAdCAM-1	 α4β7	 Adhesion	of	α4β7	subset	of	T	cells	Hyaluronan	 CD44	 Adhesion	of	neutrophils	during	liver	injury	Promotes	platelet	adhesion,	which	in	turn	enables	intrasinusoidal	CD8+	T	cell	docking	CD151	 Forms	microdomains	to	support	VCAM-1	 Firm	adhesion	of	lymphocytes	via	a	VCAM-1	mediated	pathway	CXCL9-11	 CXCR3	 Transendothelial	migration	of	T	cells	CXCL16	 CXCR6	 Mediates	T	cell	recruitment	and	NKT	cell	sinusoidal	surveillance	CX(3)CL1	 CX(3)CR1	 Adhesion	and	transmigration	of	monocytes	LSEC,	liver	sinusoidal	endothelial	cell;	NKT,	natural	killer	T;	Treg,	regulatory	T	cell	7	
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Figure 1: Microanatomy of the human liver vascular tree 2	
a | Low power image of a human liver tissue (stained with haematoxylin and eosin) 3	
illustrating the lobular organisation of the liver with zonal architecture indicated 4	
relative to the position of the portal tract. b | Expanded periportal section of the same 5	
image to illustrate the different vascular compartments within the parenchyma. c | 6	
Immunohistochemical staining of stabilin-1, which highlights liver endothelial cell 7	
distribution within hepatic tissue in a normal liver section.  8	
 9	
Figure 2 | Hepatic sinusoidal endothelial cells as antigen-presentating cells 10	
a | LSECs express MHC class I receptors and can cross-present antigen to CD8+ 11	
cytotoxic T cells. At low antigen concentrations this presentation leads to tolerance 12	
and deletion of CD8+ T cells. b | If antigen concentrations are high then antigen cross 13	
presentation to CD8+ T cells leads to a memory effector T cell phenotype. c | In the 14	
context of hepatotrophic infections such as hepatitis B, CD8+ T cells adhere to the 15	
sinusoids in a platelet-dependent process and then probe for infected hepatocytes 16	
through LSEC fenestrae. Detection of infected hepatocyte leads to diapedesis (the 17	
process of cells actively crossing capillaries)-independent killing. d | LSECs can also 18	
present antigen to CD4+ T cells via expression of MHC class II, which leads to the 19	
induction of suppressor T cells (CD25hi regulatory T cells). 20	
Figure 3 | Lymphocyte recruitment within the hepatic sinusoids 21	
Lymphocytes recruitment involves an adhesion cascade within the hepatic sinusoids 22	
that is influenced by the low shear environment and cellular cross talk between 23	
parenchymal and non-parenchymal cells. Chronic parenchymal cell damage leads to 24	
the release of DAMPs and pro-inflammatory mediators by Kupffer cells which 25	
increase adhesion molecule expression by LSECs (1). Lymphocyte recruitment 26	
across activated LSEC involves a selectin-independent tethering step (2) followed by 27	
integrin activation and firm adhesion to immunoglobulin superfamily members on the 28	
LSEC surface (3). This process is influenced by paracrine factors released from 29	
hepatocytes. Lymphocytes then crawl along the luminal endothelium (4) until they 30	
receive a signal to transmigrate across LSEC either through a paracellular or 31	
transcellular route (5). A third route of lymphocyte migration involves intracellular 32	
migration directly into the LSEC body and then migration to the adjacent LSEC, 33	
termed intracellular crawling (6). Release of chemotactic factors from activated 34	
hepatic stellate cells promotes subsequent migration and positioning in liver tissue 35	
(7).  36	
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Liver sinusoidal endothelial cells represent the most abundant non-parenchymal 15	
hepatic cell population. In this Review, the authors explore the key roles that liver 16	
sinusoidal endothelial cells have in regulating hepatic immunity, and their contribution 17	
to immune-mediated disease, liver fibrosis and carcinogenesis. 18	
